EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Subtype-specific dependencies and therapeutic opportunities in small cell lung cancer

Amanda Luvisotto iD, Rima Tulaiha, Lu Wang iD

Science Advances · 13.03.2026 · 12 (11)

DOI: 10.1126/sciadv.aea6225 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Science Advances, erschienen am 13.03.2026. Verfasst von Amanda Luvisotto und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. Hauptthemen laut MEDLINE: Lung Neoplasms, Small Cell Lung Carcinoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institutes of Health, American Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small cell lung cancer (SCLC), accounting for ~15% of lung cancers, is an aggressive and lethal tumor type. It is characterized by rapid proliferation, early metastasis, and poor prognosis. Current therapies, including platinum-based chemotherapy and recently introduced immune checkpoint inhibitors, provide modest survival benefits due to frequent relapse and therapeutic resistance. At the molecular level, SCLC is marked by near-universal loss of the tumor suppressors genes TP53 and RB1 , and exhibits marked heterogeneity driven by several key master transcription factors. These factors define distinct molecular subtypes with unique gene expression programs and therapeutic vulnerabilities, enabling cell plasticity and subtype switching in response to treatment pressures. A thorough understanding of these subtype-specific dependencies and the epigenetic mechanisms regulating transcription is critical for developing effective and durable therapies. This review focuses on these aspects and evaluates the potential of epigenetic-targeted strategies in the treatment of SCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsSmall Cell Lung CarcinomaHumansEpigenesis, GeneticGene Expression Regulation, NeoplasticTumor Suppressor Protein p53Animals

Substanzen

Tumor Suppressor Protein p53

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
  • Simpson Querrey Center for Epigenetics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

ORCID-Profile: Amanda Luvisotto, Lu Wang

Förderung

  • NIGMS NIH HHS
  • National Institutes of Health
  • American Cancer Society
  • U.S. Army Medical Research Acquisition Activity
  • Department of Defense

Zitieren

APA

Luvisotto, A., Tulaiha, R., & Wang, L. (2026). Subtype-specific dependencies and therapeutic opportunities in small cell lung cancer. Science Advances, 12(11). https://doi.org/10.1126/sciadv.aea6225

Vancouver

Luvisotto A, Tulaiha R, Wang L. Subtype-specific dependencies and therapeutic opportunities in small cell lung cancer. Science Advances. 2026;12(11). doi:10.1126/sciadv.aea6225

BibTeX
@article{Luvisotto2026,
  author = {Luvisotto, Amanda and Tulaiha, Rima and Wang, Lu},
  title = {Subtype-specific dependencies and therapeutic opportunities in small cell lung cancer},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {11},
  doi = {10.1126/sciadv.aea6225}
}
Kostenlos starten →